Objectives: To determine the accuracy of using fellow-eye biometry for intraocular lens calculations for phacovitrectomy for macula off rhegmatogenous retinal detachments.
Methods: Retrospective case review of phacovitrectomies for consecutive macula off retinal detachments over 10 years. Optical and/or ultrasound biometry was performed for affected and fellow eyes. Prediction error was determined by calculating the difference between predicted and actual refractive outcomes. Results from fellow- and same-eye biometry were compared.
Results: Forty-two eyes were included. The mean prediction errors for fellow- and same-eye biometry were -0.01 ± 1.09 and -1.22 ± 2.32 dioptres, respectively, indicating a myopic shift for same eye biometry calculations. The mean absolute prediction errors for fellow and same eye biometry were 0.73 ± 0.80 and 1.57 ± 2.08 dioptres, respectively. The difference was statistically significant (P = 0.016).
Conclusions: When appropriate, intraocular lens calculations using fellow-eye biometry for phacovitrectomy for macula off rhegmatogenous retinal detachments are accurate and better than those from same-eye biometry.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002476 | PMC |
http://dx.doi.org/10.1038/s41433-019-0485-0 | DOI Listing |
Objectives: To evaluate the efficacy, safety, and stability of EyeCryl Phakic intraocular lens (IOL) implantation.
Methodology: This retrospective study was conducted in Maghrabi Hospital in Medina to review 31 patients who underwent posterior chamber phakic IOL (EyeCryl Phakic IOL) for surgical correction of myopia or astigmatism. The data were collected from patient medical records after obtaining their consents.
J Cataract Refract Surg
January 2025
Coastal Vision Medical Group, Orange, CA, USA.
Purpose: To investigate the safety and refractive outcomes of neodymium-doped yttrium-aluminum-garnet (Nd:YAG) capsulotomy in pseudophakic eyes with the Light Adjustable Lens (LAL) both before and after completing the light delivery device (LDD) lock-in treatments.
Setting: Private practice in Orange, California, USA.
Design: Retrospective, comparative study.
J Cataract Refract Surg
January 2025
Faculty of Medicine, University of New South Wales, Kensington, NSW, Australia.
J Cataract Refract Surg
January 2025
Aros Private Hospital, Aarhus, Denmark (Olsen).
Purpose: We analyzed intraocular lens (IOL) power calculation in a series of patients with a zero diopter power implant. The idea was to bypass the Estimated Lens Plane (ELP), an important variable in normal IOL calculation.
Setting: Large multi-center group practice.
J Control Release
January 2025
Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk 37673, Republic of Korea. Electronic address:
Although smart contact lenses have demonstrated great potential in theranostics, there remain critical challenges and opportunities in their commercial development. In this Perspective, the current status and capability of smart theranostic contact lenses are highlighted, focusing on their application as sensing systems for detecting biomarkers such as glucose, intraocular pressure (IOP), and inflammatory cytokines, and as drug delivery systems (DDS) for precise and controlled therapy. Additionally, key challenges associated with clinical development and commercialization of smart theranostic contact lenses are discussed, to optimize diagnostic and therapeutic interventions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!